Q&A With W. Frank Peacock IV From Baylor College of Medicine: Taking a Closer Look at Benefits and Risks of Rivaroxaban

Video

As oral anticoagulants become more popular and a new generation of the drugs is introduced there are still some questions about the potential risks of taking the medication and whether they outweigh the benefits.

As oral anticoagulants become more popular and a new generation of the drugs is introduced there are still some questions about the potential risks of taking the medication and whether they outweigh the benefits.

W. Frank Peacock IV, MD, from the Baylor College of Medicine discussed this balancing act for doctors during the European Society of Cardiology's annual congress in London.

Patients who take oral anticoagulants are always made aware of potential bleeding risks that come with the medication. How doctors approach those risks and move forward can determine a patient's understanding of their condition in their daily lives.

Related Videos
Ankeet Bhatt, MD, MBA | Credit: X.com
Sara Saberi, MD | Credit: University of Michigan
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Albert Foa, MD, PhD | Credit: HCPLive
Veraprapas Kittipibul, MD | Credit: X.com
Heart Failure stock imagery. | Credit: Fotolia
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Building a Psoriasis Knockout Regimen Around Risankizumab, with Andrew Blauvelt, MD, MBA
© 2024 MJH Life Sciences

All rights reserved.